pocketful logo light
pocketful logo light
RPG Life Sciences Ltd logo

RPG Life Sciences Ltd

NSE: RPGLIFE BSE: 532983

₹2300.20

(0.01%)

Wed, 27 May 2026, 05:43 pm

RPG Life Sciences Share Price Live Chart

1 Day

(0.01%)

No Result Found

Summary

  • Market Cap

    3657.52

  • Net Profit

    183.24

  • P/B

    7.10

  • Sector P/E

    34.32

  • P/E

    20.56

  • EV/EBITDA

    14.17

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    25.53

  • ROCE

    32.28

  • Debt/Equity

    0

  • EPS (TTM)

    67.87

  • Dividend Yield

    1.09

  • Book Value

    366.01

  • Interest Cover

    93.37

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are thoroughly covered by earnings (7.3x coverage).
  • RPG Life Sciences's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • RPG Life Sciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • RPG Life Sciences is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • RPG Life Sciences's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • Yugal Kishor's remuneration is higher than average for companies of similar size in India.
  • RPG Life Sciences is not covered by any analysts.

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters72.9572.9572.9572.9572.95
FII0.871.001.111.351.45
DII7.457.046.706.486.14
Public18.7319.0119.2419.2219.46
Government00000

Read More

Technical Analysis

RSI

51.18

MACD

45.74

50 DMA

2074.38

200 DMA

2199.42

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic3149.732653.532474.272157.331978.071661.131164.93
Fibonacci2653.532463.982346.882157.331967.781850.681661.13
Camarilla2431.452385.972340.492157.332249.512204.032158.55

Pivots Level: Classic

R3

+992.40

3149.73

R2

+496.20

2653.53

R1

+316.93

2474.27

2157.33
2157.33
Pivot Point
LTP: 2232.60

S1

-179.27

1978.07

S2

-496.20

1661.13

S3

-992.40

1164.93

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2268.90

  • 20-EMA

    2248.67

  • 30-EMA

    2207.84

  • 50-EMA

    2151.64

  • 100-EMA

    2128.13

  • 200-EMA

    2157.06

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 Apr 2026board-meetingsAccounts, Quarterly Results, Final Dividend
27 Jan 2026board-meetingsQuarterly Results
14 Jun 2025agm
27 May 2025dividendFinal Dividend - Rs. - 2027 Jun 2025
28 Apr 2025dividend₹20.00 Dividend /Share27 Jun 2025
11 Jun 2024agm
28 May 2024dividendFinal Dividend - Rs. - 1628 Jun 2024
30 Apr 2024dividend₹16.00 Dividend /Share28 Jun 2024
07 Jul 2023agm
21 Jun 2023dividendFinal Dividend - Rs. - 1221 Jul 2023

Read More

Peer Comparison

RPG Life Sciences Ltd logo

RPG Life Sciences Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Read More

RPG Life Sciences Ltd About

RPG Life Sciences is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2007

Headquarters

CEO

H V Goenka

Employees

Contact

Website icon

Website

http://www.rpglifesciences.com

Email icon

Email

info@rpglifesciences.com

Phone icon

Phone

91-022-24981650

Location icon

Location

RPG House, 463 Dr Annie Besant Road Worli, Mumbai, Maharashtra, 400030

Read More

RPG Life Sciences Ltd Company History

YearHistory
2013
  • RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility
  • RPG Life Sciences bagged 'Asia's Best Employer Brand Awards 2013' in Singapore.
2014
  • Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014.
2015
  • RPG Life Plans Skincare Foray
2016
  • RPG Life Sciences announces foray into Cosmetic Industry
  • RPG Life Sciences to expand its formulations business
  • RPG Life gains over 14 percent on getting EUGMP certification
2019
  • RPG Life Sciences enters Anti-Diabetic therapeutic area.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy1098012257.0230 Apr 2026
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell1098012258.7330 Apr 2026
XTX MARKETS LLPbulkBuy135708730.5321 Sept 2021
XTX MARKETS LLPbulkSell136929731.4721 Sept 2021
XTX MARKETS LLPbulkSell85613597.0803 Sept 2021
XTX MARKETS LLPbulkBuy8962459603 Sept 2021
XTX MARKETS LLPbulkBuy162323566.9101 Sept 2021
XTX MARKETS LLPbulkSell159973568.0901 Sept 2021
M/S MENTOR CAPITAL LIMITEDbulkSell327584294.3106 Jan 2020
AUTHUM INVESTMENT & INFRASTRUCTURE LIMITEDbulkBuy327584294.3106 Jan 2020

Read More

RPG Life Sciences Ltd News

RPG Life Sciences Investor Conference on May 26

RPG Life Sciences Limited will hold its Annual Investor Conference on May 26, 2026. The meeting will be conducted in person.

22 May 2026

companies

RPG Life Sciences Q4 FY26 Earnings Call Transcript Available

RPG Life Sciences FY26 revenue Rs. 70,752 lakhs, net profit Rs. 11,517 lakhs, Rs. 24 dividend recommended; Q4 FY26 earnings call transcript now available on company website.

09 May 2026

companies

RPG Life Sciences Q4 FY26 Earnings Call Transcript Available

RPG Life Sciences FY26 revenue Rs. 70,752 lakhs, net profit Rs. 11,517 lakhs, Rs. 24 dividend recommended; Q4 FY26 earnings call transcript now available on company website.

08 May 2026

companies

RPG Life Sciences Reports FY26 Annual Results

RPG Life Sciences posts FY26 revenue from operations of Rs. 70,752 lakhs, net profit of Rs. 11,517 lakhs, and recommends a dividend of Rs. 24 per share.

07 May 2026

companies

RPG Life Sciences Q4 FY26: Revenue up 23.6% to Rs 176.9 Cr

RPG Life Sciences reported Q4 FY26 revenue of Rs 176.9 crore, up 23.6% YoY. PAT grew 58.1% to Rs 29.3 crore, EBITDA rose 48% to Rs 45.2 crore with margin at 25.6%. Board recommended Rs 24 dividend.

01 May 2026

companies

Read More